Peter Brandt
Director/Board Member bei IN8BIO, INC.
Vermögen: 436 281 $ am 31.03.2024
Profil
Peter C.
Brandt is an Independent Director at IN8bio, Inc. He was the President, Chief Executive Officer & Director at Noven Pharmaceuticals, Inc. from 2008 to 2009.
He served as the Interim President & Chief Executive Officer at Epocrates LLC from 2011 to 2012.
He was the President & Chief Executive Officer at Epocrates, Inc. (Research).
He was an Independent Director at Auxilium Pharmaceuticals LLC from 2011 to 2015 and at Rexahn Pharmaceuticals, Inc. from 2010 to 2015.
He was the President-Pharmaceutical Operations at Pfizer Inc. from 1981 to 2007 and Senior VP-Finance, Planning & Business Development at Pfizer Health Solutions, Inc. from 2005 to 2005.
He received his undergraduate degree from the University of Connecticut and his MBA from Columbia Business School.
Currently, he is an Independent Director at IN8bio, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IN8BIO, INC.
0,85% | 13.12.2023 | 369 730 ( 0,85% ) | 436 281 $ | 31.03.2024 |
Aktive Positionen von Peter Brandt
| Unternehmen | Position | Beginn |
|---|---|---|
| IN8BIO, INC. | Director/Board Member | 01.07.2019 |
Ehemalige bekannte Positionen von Peter Brandt
| Unternehmen | Position | Ende |
|---|---|---|
| AUXILIUM PHARMACEUTICALS, INC. | Director/Board Member | 29.01.2015 |
Epocrates LLC
 Epocrates LLC Medical SpecialtiesHealth Technology Epocrates LLC provides clinical tools and solutions. The firm provides the healthcare industry, primarily pharmaceutical companies, and opportunities to engage with its user network through delivery of targeted information and to conduct market research. The company was founded by Richard Fiedotin and Jeff Tangney on August 1998 and is headquartered in San Mateo, CA. | Chairman | 12.03.2013 |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Chief Executive Officer | 14.07.2009 |
| PFIZER, INC. | Corporate Officer/Principal | 01.05.2007 |
Pfizer Health Solutions, Inc.
 Pfizer Health Solutions, Inc. Medical DistributorsDistribution Services Pfizer Health Solutions, Inc. develops and implements health technology solutions. It develops and implements clinical technology solutions. The company was founded on August 3, 2000 and is headquartered in New York, NY. | Director of Finance/CFO | 01.12.2005 |
Ausbildung von Peter Brandt
| University of Connecticut | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| IN8BIO, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
Auxilium Pharmaceuticals LLC
 Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
Epocrates LLC
Epocrates LLC Medical SpecialtiesHealth Technology Epocrates LLC provides clinical tools and solutions. The firm provides the healthcare industry, primarily pharmaceutical companies, and opportunities to engage with its user network through delivery of targeted information and to conduct market research. The company was founded by Richard Fiedotin and Jeff Tangney on August 1998 and is headquartered in San Mateo, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
Pfizer Health Solutions, Inc.
Pfizer Health Solutions, Inc. Medical DistributorsDistribution Services Pfizer Health Solutions, Inc. develops and implements health technology solutions. It develops and implements clinical technology solutions. The company was founded on August 3, 2000 and is headquartered in New York, NY. | Distribution Services |
Epocrates, Inc. (Research)
 Epocrates, Inc. (Research) Investment ManagersFinance Founded in 1998, Epocrates, Inc. Research is an investment research firm located in Ewing, New Jersey. The firm is a subsidiary of Epocrates, Inc. (NasdaqGM: EPOC), a San Mateo, California-based company that develops clinical information and decision support tools for healthcare professionals. | Finance |
